Willius Pharmaceuticals Private Limited
About Willius Pharmaceuticals Private Limited
Data last updated:
Willius Pharmaceuticals Private Limited is a private limited company based in Jahagirpuri, Delhi, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 06 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2021PTC375321. Its GSTIN is 10AACCW8479N1ZR (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Dimpal Kumari Singh and Mausam Sinha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Neetu Aryan H. No. – 356 Ist Floor Near Iti Mig Dda Flats, Jahagirpuri, Delhi, India – 110033.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.37 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹36,976 (net margin -8.5%) and EBITDA of ₹69,582 (EBITDA margin 15.9%). Revenue has grown at a compounded annual rate (CAGR) of 99% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Neetu Aryan H. No. – 356 Ist Floor Near Iti Mig Dda Flats, Jahagirpuri, Delhi, India – 110033
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Willius Pharmaceuticals Private Limited
The main business activity of Willius Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Willius Pharmaceuticals Private Limited FY 2025 filings available
Willius Pharmaceuticals Private Limited reported revenue of ₹4.37 Lakh (up 395% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Willius Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 99% over three years, including 395% growth in the latest year. EBITDA rose 180% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Willius Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹69,582 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹36,976 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Willius Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -8.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Willius Pharmaceuticals are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Willius Pharmaceuticals Private Limited
Willius Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rightex Pharmaceuticals Private Limited | ₹4.43 Lakh (FY 2025) | •••• | •••• | -36.0% | •••• | Jalgaon, Maharashtra, India |
| Native Pharmaceuticals Private Limited | ₹4.41 Lakh (FY 2025) | •••• | •••• | •••• | Srinagar, Jammu & Kashmir, India | |
| Arjita Pharmaceuticals Private Limited | ₹4.41 Lakh (FY 2024) | •••• | •••• | -45.0% | •••• | Muzaffarpur, Bihar, India |
| Sanchi Pharmaceuticals Private Limited | ₹4.4 Lakh (FY 2024) | •••• | •••• | -1.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Fairfield Pharmaceuticals Private Limited | ₹4.39 Lakh (FY 2025) | •••• | •••• | 34.0% | •••• | Gujarat, India |
| Willius Pharmaceuticals Private Limited this company | ₹4.37 Lakh (FY 2025) | •••• | •••• | 395.0% | •••• | Jahagirpuri, Delhi, India |
| Yeslife Pharmaceuticals Limited | ₹4.37 Lakh (FY 2022) | •••• | •••• | 119.0% | •••• | New Delhi, Delhi, India |
| Birmshire Pharmaceuticals Private Limited | ₹4.36 Lakh (FY 2024) | •••• | •••• | -34.0% | •••• | New Delhi, Delhi, India |
| Aidsoulasia Pharmaceuticals Private Limited | ₹4.36 Lakh (FY 2023) | •••• | •••• | -9.0% | •••• | Noida, Uttar Pradesh, India |
| Martel Hammer Pharmaceuticals Private Limited | ₹4.35 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | Mumbai, Maharashtra, India |
| Markus Pharmaceuticals Private Limited | ₹4.35 Lakh (FY 2023) | •••• | •••• | •••• | Alappuzha, Kerala, India |
Peers are the five companies nearest above and the five nearest below Willius Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Willius Pharmaceuticals Private Limited
Willius Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mausam Sinha Also directs: Biocius Pharmaceuticals Private Limited | Additional Director | 30 Mar 2023 | 3 Years 6 Months | Current |
| Dimpal Kumari Singh | Director | 06 Jan 2021 | 5 Years 9 Months | Current |
Ownership and Shareholding of Willius Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Willius Pharmaceuticals Private Limited
Willius Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Willius Pharmaceuticals Private Limited
Willius Pharmaceuticals Private Limited has a workforce of 0 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Willius Pharmaceuticals Private Limited
Willius Pharmaceuticals Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Manish Kumar ceased to be Director on 30 Mar 2023.
Credit Ratings, Litigation & Regulatory Alerts for Willius Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Willius Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Willius Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Willius Pharmaceuticals Private Limited
Willius Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AACCW8479N1ZR | Bihar | Active | 01 Mar 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Willius Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Willius Pharmaceuticals Private Limited
Willius Pharmaceuticals is an active private limited company based in Jahagirpuri, Delhi, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 06 January 2021 (5+ years old) and is registered under CIN U24304DL2021PTC375321.
Willius Pharmaceuticals reported revenue of ₹4.37 Lakh for FY 2025 (up 395% YoY).
Willius Pharmaceuticals has 2 current directors:
- Mausam Sinha - Additional Director
- Dimpal Kumari Singh - Director
Willius Pharmaceuticals reported a net loss of ₹36,976 (net margin -8.5%) and EBITDA of ₹69,582 (EBITDA margin 15.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Willius Pharmaceuticals is 99% over three years. In the latest year (FY 2025) revenue rose 395%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Willius Pharmaceuticals is 10AACCW8479N1ZR, registered in Bihar.
The CIN (Corporate Identification Number) of Willius Pharmaceuticals is U24304DL2021PTC375321. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Willius Pharmaceuticals was incorporated on 06 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Willius Pharmaceuticals by revenue are Rightex Pharmaceuticals Private Limited, Native Pharmaceuticals Private Limited, Arjita Pharmaceuticals Private Limited, Sanchi Pharmaceuticals Private Limited, Fairfield Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Manish Kumar ceased to be Director on 30 Mar 2023. Mausam Sinha was appointed as Additional Director on 30 Mar 2023. Dimpal Kumari Singh was appointed as Director on 06 Jan 2021.
The registered office of Willius Pharmaceuticals is at CO Neetu Aryan H. No. – 356 Ist Floor Near Iti Mig Dda Flats, Jahagirpuri, Delhi, India – 110033.